Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...

About 30 million people around the world have grown legally blind due to retinal diseases. The EPI-RET project has sought for a technical solution for the past twelve years to help these patients.

An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...

A retinal prosthesis system can safely, effectively, and reliably restore enough visual function to patients with late-stage retinitis pigmentosa to improve object detection and overall well-being, ...

Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing ...

An editorial published in the New England Journal of Medicine 1 referred to the Photovoltaic Retina Implant Microarray (PRIMA ...

Retinitis pigmentosa and age-related macular degeneration are two significant causes of severe visual dysfunction. In both, the retinal photoreceptors degenerate, preventing successful conversion of ...

The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain's visual cortex, has been successfully surgically implanted in the ...

Professor of Neurosurgery and Radiation Oncology and affiliated faculty in Bioengineering and Neuroscience, UCLA Medical Center & UCLA Brain Research Institute Stimulation of human visual cortex is ...

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Blind patients with no or bare light perception implanted with a visual cortical prosthesis have ...